Safety and efficacy of using portable coagulation monitor for INR examination after left-sided mechanical prosthetic valve replacement

Table 1 Baseline data and follow-up data at 3rd -month postoperative

Item	Self-management	Conventional	p
Female, n	26	81	0.692
Age (years), mean ± SD	52.01 ± 11.84	51.49 ± 11.19	0.832
BMI (kg/m²), mean ± SD	22.35 ± 2.01	22.51 ± 2.33	0.874
Diabetes, n	5	17	0.755
Hypertension, n	10	41	0.270
Surgical type, n			0.895
Mitral valve	27	76
Aortic valve	19	61
Mitral and aortic valve	8	21
Prosthetic valve type, n			0.521
CarboMedics	15	29
ATS	18	58
St-Jude medical	23	77
St-Jude regent	6	15
Cox-Maze procedure, n	9	22	0.622
Tricuspid annuloplasty, n	14	32	0.142
Endoscopic mitral surgery, n	12	31	0.331
Atrial fibrillation, n	17	55	0.656
LVED (%), mean ± SD	59.45 ± 6.47	58.92 ± 6.13	0.638
LVEF (%), mean ± SD	62.14 ± 7.99	61.98 ± 7.76	0.722
NYHA, median (IQR)	1 (0)	1 (0)	0.784

BMI body mass index, LVEF left ventricular ejection fraction, LVED left ventricular end diastolic diameter, NYHA New York Heart Association classification

ISSN: 1749-8090